Fact CheckerSign in

NCT07624565Not yet recruiting

Accelerating Access and Improving Imaging in Heart Failure Care (A2I2HF) Pilot Study

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

This is a prospective, multicenter, cluster randomised trial which will assess the feasibility and acceptability of AI-assisted point of care echocardiography on HF detection and downstream care processes for patients with suspected HF discharged from the Emergency Department.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
84 (estimated)
First submitted
25 May 2026
Start date
29 Sept 2026
Primary completion date
29 Nov 2027
Lead sponsor
University of Alberta
NCT number
NCT07624565

What you commit to

  • Study type: Interventional
  • Planned participants: 84
  • From 29 Sept 2026 to the primary completion date, 29 Nov 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • prior documented diagnosis of HF;
  • any patient receiving renal replacement therapy;
  • any patient receiving comfort or palliative care;

Other

  • pregnant or nursing patients;
  • patients planned for admission
  • Investigator/treating physician discretion: any patient not suitable for participation for other reasons

Who the study is looking for

  • Adult patients age ≥18 years presenting to the ED;
  • with signs or symptoms of HF as per the treating physician and
  • elevated natriuretic peptides (NT-proBNP\>125pg/mL or BNP\>50pg/mL); drawn as part of standard of care of evaluation in the ED, OR age≥ 40 years and ≥1 HF risk factor:
    • Established diagnosis of type 2 diabetes
    • Coronary artery disease (prior documented type 1 myocardial infarction or coronary artery bypass grafting or percutaneous coronary intervention or documented stenosis of an epicardial coronary artery (\>50% left main or \>70% left anterior descending, circumflex or right coronary artery)
    • Previous ischemic or embolic stroke
    • Peripheral artery disease (previous surgical or percutaneous revascularization or a documented stenosis greater than 50% of a major peripheral arterial vessel).
    • Regular loop diuretic use

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.